CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +7,175 | $13.81 | $99K | 149,086 |
| 2023-07-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +2,825 | $8.11 | $23K | 151,911 |
| 2023-07-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 7,505 | ||
| 2023-07-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −7,175 | 26,825 | ||
| 2023-07-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −2,825 | 75,627 | ||
| 2023-06-21 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $18.41 | $184K | 151,911 |
| 2023-06-21 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $36.00 | $360K | 141,911 |
| 2023-06-21 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 17,505 | ||
| 2023-05-05 | Posard Matthew L. Director | Grant or award | +8,065 | 113,254 | ||
| 2023-05-05 | Posard Matthew L. Director | Grant or award · Option to Purchase Common Stock | +11,371 | 11,371 | ||
| 2023-05-05 | Miyashita Akiko Moni Director | Grant or award | +8,065 | 14,271 | ||
| 2023-05-05 | Miyashita Akiko Moni Director | Grant or award · Option to Purchase Common Stock | +11,371 | 11,371 | ||
| 2023-05-05 | MATSUI CONNIE Director | Grant or award | +8,065 | 187,004 | ||
| 2023-05-05 | MATSUI CONNIE Director | Grant or award · Option to Purchase Common Stock | +11,371 | 11,371 | ||
| 2023-05-05 | Henderson Jeffrey William Director | Grant or award | +8,065 | 47,110 | ||
| 2023-05-05 | Henderson Jeffrey William Director | Grant or award · Option to Purchase Common Stock | +11,371 | 11,371 | ||
| 2023-05-05 | Duncan Barbara Gayle Director | Grant or award | +8,065 | 9,253 | ||
| 2023-05-05 | Duncan Barbara Gayle Director | Grant or award · Option to Purchase Common Stock | +11,371 | 11,371 | ||
| 2023-05-05 | Daly James M Director | Grant or award | +8,065 | 40,503 | ||
| 2023-05-05 | Daly James M Director | Grant or award · Option to Purchase Common Stock | +11,371 | 11,371 |
Page 38 of 48 · 944 trades